Perioperative medicine & outcomes

Day-of-surgery quality gaps in glycemic management: a retrospective cohort study

Perioper Med (Lond)Published Retrospective cohort study

Authors' conclusion

There were important quality gaps in glucose measurement and hyperglycemia treatment for patients with diabetes. Hyperglycemia was common and clinically significant among patients without diabetes.

Study context

Population
Adults with and without diabetes undergoing surgery at 6 hospitals in Alberta, Canada, 2019–2024
Participants
12,275 eligible procedures
Exposure
Diabetes vs Prediabetes vs No diabetes vs Unknown diabetes status
  • Diabetesn = 3,164
Outcome
Process, outcome and balancing measures of day-of-surgery glycemic management
Follow-up
Day of surgery
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Day-of-surgery glucose measurement, hyperglycemia and insulin treatment
GroupValue≥1 glucose measurementHyperglycemiaInsulin given if hyperglycemic
Diabetes85.4%85.4% (n = 2,703)37.1% (n = 1,004)51.4% (n = 516)

Diabetes

Value85.4%
≥1 glucose measurement85.4% (n = 2,703)
Hyperglycemia37.1% (n = 1,004)
Insulin given if hyperglycemic51.4% (n = 516)

Observational data: associations, not effects.

Further findings

Outcomes of day-of-surgery hyperglycemia (BG ≥ 10.0 mmol.L-1), exploratory analysis

aOR (95% CI)P value
HyperglycemiaPostoperative ICU admission · exploratory analysis5.37 (4.45–6.49)P < 0.001
Hyperglycemia30-day readmission · exploratory analysis2.19 (1.89–2.54)P < 0.0001
OutcomeLOS (days) (95% CI)P value
Outcomes of day-of-surgery hyperglycemia (BG ≥ 10.0 mmol.L-1), exploratory analysisHyperglycemia · longer LOS · exploratory analysis4.49 (4.70–5.18)P < 0.0001

Original publication

Day-of-surgery quality gaps in glycemic management: a retrospective cohort study. Perioper Med (Lond). Published 25 November 2025. doi:10.1186/s13741-025-00628-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.